<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-29T16:54:00Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/117130" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/117130</identifier><datestamp>2025-03-18T12:22:46Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Cardiac electrophysiological effects of remifentanil: study in a closed-chest porcine model</dc:title>
   <dc:creator>Zaballos García, Matilde</dc:creator>
   <dc:creator>Jimeno, Concepcion</dc:creator>
   <dc:creator>Almendral Garrote, Jesús</dc:creator>
   <dc:creator>Atienza Fernández, Felipe</dc:creator>
   <dc:creator>Patiño, Daniel</dc:creator>
   <dc:creator>Valdés, Esther</dc:creator>
   <dc:creator>Navia Roque, Juan</dc:creator>
   <dc:creator>Anadón Baselga, María José</dc:creator>
   <dc:subject>617-089.5</dc:subject>
   <dc:subject>Ciencias Biomédicas</dc:subject>
   <dc:subject>32 Ciencias Médicas</dc:subject>
   <dc:description>Background. Remifentanil has been implicated as causing intraoperative bradyarrhythmias, but little information is available regarding its cardiac electrophysiological effects. Thus, we evaluated the cardiac electrophysiological properties before and after remifentanil in a closed- chest porcine model.
Methods. Eighteen Landrace–Large pigs were premedicated with ketamine and anaesthetized with propofol (4.5 mg kg21 bolus followed by 13 mg kg21 h21). After instrumentation, an elec- trophysiological evaluation was performed under propofol and repeated after remifentanil (bolus of 1 mg kg21, followed by an infusion of 0.5 mg kg21 min21). We evaluated sinus node function [sinus node recovery time (SNRT) and sinoatrial conduction time (SACT)], atrioven- tricular (AV) nodal function [AH intervals during sinus rhythm (SR) and atrial pacing, Wenckebach cycle length (WCL), and effective refractory periods (ERP)], atrial, His-Purkinje, and ventricular conduction and refractoriness. Significant changes between ‘propofol protocol’ and ‘propofolþremifentanil protocol’ were evaluated.
Results. Remifentanil caused a significant increase in sinus cycle length (21%, P1⁄40.001) and a significant prolongation of SNRT (43%, P1⁄40.001), corrected SNRT (136%, P1⁄40.003), SACT (40%, P1⁄40.005), AH interval during SR (17%, P1⁄40.02), AH interval during atrial pacing (25%, P1⁄40.01), and ventricular ERP (12%, P1⁄40.004). There was a tendency towards a prolongation of WCL and AV nodal refractoriness. Similar significant changes were observed in a reference group of seven animals in which sevoflurane was used instead of propofol. No significant changes were observed in atrial parameters, His-Purkinje function, parameters of intraventricu- lar conduction, and QT intervals.
Conclusions. Remifentanil depresses sinus node function and most parameters of AV nodal function. This contributes to an explanation for clinical observations of remifentanil-related severe bradyarrhythmias.</dc:description>
   <dc:description>Depto. de Medicina Legal, Psiquiatría y Patología</dc:description>
   <dc:description>Fac. de Medicina</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2025-01-30T10:04:39Z</dc:date>
   <dc:date>2025-01-30T10:04:39Z</dc:date>
   <dc:date>2009</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/117130</dc:identifier>
   <dc:identifier>0007-0912</dc:identifier>
   <dc:identifier>10.1093/bja/aep131</dc:identifier>
   <dc:identifier>1471-6771</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Zaballos M, Jimeno C, Almendral J, Atienza F, Patiño D, Valdes E, Navia J, Anadón MJ. Cardiac electrophysiological effects of remifentanil: study in a closed-chest porcine model. Br J Anaesth. 2009 Aug;103(2):191-8. doi: 10.1093/bja/aep131</dc:relation>
   <dc:rights>restricted access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Elsevier</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>